NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity

Active Not RecruitingEARLY_Phase 1

Sponsor: University of Connecticut

Conditions: Dyslipidemias, Obesity

Interventions: Milk Polar Lipid-Rich Dairy Powder, Dairy Powder

Countries: United States

The major objective of this project is to examine whether daily consumption of milk polar lipids (MPLs) influences cardiometabolic risk factors.

Eligibility overview

Sex: ALL

Age: 18 Years to 70 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* LDL-C ≥ 130 mg/dL
* Waist circumference ≥ 88 cm for women, ≥ 102 cm for men
* Aged 18 to 70 years

Exclusion Criteria:

* Renal disease
* Liver disease
* Diabetes
* Heart disease
* Stroke
* Cancer
* Eating disorders
* Thyroid disease
* Gut-associated pathologies
* Autoimmune diseases
* Chronic inflammatory diseases
* Scleroderma
* Gallbladder disease
* Blood clotting disorders
* Intravenous drug use
* Fasting plasma/serum triglycerides \>500 mg/dL
* Fasting plasma/serum glucose \>126 mg/d
* Weight changes \>10% over last 4 weeks
* Oral antibiotics use up to 1 month prior to and during study
* Allergy or intolerance to milk products
* Taking lipid-lowering medications (e.g., statins, fibrates)
* Taking anti-inflammatory medications (e.g., corticosteroids)
* Taking medications which primarily affect blood clotting (e.g., warfarin).

Locations (1)

Storrs, Connecticut, United States